DUBLIN--(BUSINESS WIRE)--Aug 23, 2018--The "Stereotactic Surgery Devices Market Size, Share & Trends Analysis Report By Type (Gamma Knife, Linear Accelerator, CyberKnife, Proton Beam Therapy), By Region, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global stereotactic surgery devices market size is expected to reach USD 25.9 billion by 2025, expanding at a CAGR of 6.1% during the forecast period.

Stereotactic surgery is a minimally invasive alternative for traditional invasive ablation and biopsy methods. Since, stereotactic surgery has various advantages such as higher efficacy, minimal or no surgical incisions, and lower risk of damage to healthy cells, it is replacing conventional radiotherapies. These surgical procedures have helped overcome drawbacks associated with traditional invasive surgeries, such as destruction of healthy cells and higher risk of recurrence & postoperative complications.

Only around 10.0% of the population in low and middle-income countries have access to radiation therapy, owing to dearth of radiation therapy devices. A market leader, Elekta, in its 2016 annual report stated that the number of installations of linear accelerators in high-income countries was approximately 13,000, whereas the requirement was around 25,000. Hence, huge demand-supply discrepancy of radiotherapy devices is likely to open new avenues for major market players in developing countries.

Some of the major players operating in the market are Siemens Ag, Elekta AB, Varian Medical Systems, IBA, and Accuray Incorporated

Key Topics Covered:

Chapter 1 Report Scope

Chapter 2 Research Methodology

Chapter 3 Objective

Chapter 4 Executive Summary

Chapter 5 Market Definitions

Chapter 6 Industry Outlook

Chapter 7 Stereotactic Surgery Devices Market: Product Estimates & Trend Analysis

Chapter 8 Stereotactic Surgery Devices Market: Regional Estimates & Trend Analysis, by Product Type

Chapter 9 Competitive Landscape

AstraZeneca Bayer AG Merck KGaA Abbott Pfizer, Inc. Sanofi Bristol Myers Squibb Company Teva Pharmaceutical Industries Ltd. Novartis AG Ferring B.V.

For more information about this report visit https://www.researchandmarkets.com/research/c2vj9f/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180823005691/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Surgical Devices

KEYWORD:

INDUSTRY KEYWORD: SURGERY HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/23/2018 02:57 PM/DISC: 08/23/2018 02:57 PM

http://www.businesswire.com/news/home/20180823005691/en